- Home
- Publications
- Publication Search
- Publication Details
Title
Koschei the immortal and anti-aging drugs
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 5, Issue 12, Pages e1552-e1552
Publisher
Springer Nature
Online
2014-12-05
DOI
10.1038/cddis.2014.520
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Growth and aging: a common molecular mechanism
- (2016) Mikhail V. Blagosklonny et al. Aging-US
- Validation of anti-aging drugs by treating age-related diseases
- (2016) Mikhail V. Blagosklonny Aging-US
- Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
- (2016) Mikhail V. Blagosklonny Aging-US
- Chemoprevention of age-related macular regeneration (AMD) with rapamycin
- (2016) X. F. Steven Zheng Aging-US
- Tumor suppression by p53 without apoptosis and senescence: conundrum or rapalog-like gerosuppression?
- (2016) Mikhail V. Blagosklonny Aging-US
- Rapamycin as longevity enhancer and cancer preventative agent in the context of p53 deficiency
- (2016) Lawrence A. Donehower Aging-US
- Brown-to-white transition in subcutaneous fat: linking aging and disease
- (2016) Nicole H Rogers et al. Aging-US
- Answering the ultimate question “What is the Proximal Cause of Aging?”
- (2016) Mikhail V. Blagosklonny Aging-US
- Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
- (2016) Elena A. Komarova et al. Aging-US
- Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling
- (2016) H. Dorota Halicka et al. Aging-US
- New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53−/− mice by delaying carcinogenesis
- (2016) Maria Comas et al. Aging-US
- Inflammatory cause of metabolic syndrome via brain stress and NF-κB
- (2016) Dongsheng Cai et al. Aging-US
- Will calorie restriction work in humans?
- (2016) Edda Cava et al. Aging-US
- Prolonged Rapamycin treatment led to beneficial metabolic switch
- (2016) Yimin Fang et al. Aging-US
- Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
- (2016) Lan Ye et al. Aging-US
- Treating fatty liver and insulin resistance
- (2016) Rachel J. Perry et al. Aging-US
- Rapamycin extends life span of Rb1+/− mice by inhibiting neuroendocrine tumors
- (2016) Carolina B. Livi et al. Aging-US
- Metformin, aging and cancer
- (2016) Olga Moiseeva et al. Aging-US
- Lipid-induced hepatic insulin resistance
- (2016) Thomas Galbo et al. Aging-US
- PP2A inhibition results in hepatic insulin resistance despite Akt2 activation
- (2016) Thomas Galbo et al. Aging-US
- Rapamycin extends life- and health span because it slows aging
- (2016) Mikhail V. Blagosklonny Aging-US
- Dietary and genetic effects on age-related loss of gene silencing reveal epigenetic plasticity of chromatin repression during aging
- (2016) Nan Jiang et al. Aging-US
- Rapamycin in preventive (very low) doses
- (2016) Roman V. Kondratov et al. Aging-US
- Target of rapamycin signalling mediates the lifespan-extending effects of dietary restriction by essential amino acid alteration
- (2016) Sahar Emran et al. Aging-US
- Rapamycin-induced metabolic defects are reversible in both lean and obese mice
- (2016) Yuhong Liu et al. Aging-US
- BMAL1-dependent regulation of the mTOR signaling pathway delays aging
- (2016) Rohini V. Khapre et al. Aging-US
- Beta-adrenergic signaling, a novel target for cancer therapy?
- (2015) Oncotarget
- Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
- (2015) Oncotarget
- Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment
- (2015) Alberto M. Martelli et al. Oncotarget
- A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia
- (2015) Francesca Chiarini et al. Oncotarget
- The connection between lymphangiogenic signalling and prostaglandin biology: A missing link in the metastatic pathway
- (2015) Tara Karnezis et al. Oncotarget
- Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells
- (2015) Håkon Reikvam et al. Oncotarget
- Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1
- (2015) Maria Giovanna Francipane et al. Oncotarget
- Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin
- (2015) Silvia Cufi et al. Oncotarget
- Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet
- (2014) Olga V. Leontieva et al. AGING CELL
- Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin
- (2014) Irina G Popovich et al. CANCER BIOLOGY & THERAPY
- M(o)TOR of pseudo-hypoxic state in aging: Rapamycin to the rescue
- (2014) Olga V. Leontieva et al. CELL CYCLE
- Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome
- (2014) Wilson C. Fok et al. PLoS One
- Beneficial Metabolic Effects of Rapamycin Are Associated with Enhanced Regulatory Cells in Diet-Induced Obese Mice
- (2014) Kassem Makki et al. PLoS One
- Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program
- (2014) O. V. Leontieva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Defects in TLR3 expression and RNase L activation lead to decreased MnSOD expression and insulin resistance in muscle cells of obese people
- (2014) O Fabre et al. Cell Death & Disease
- Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
- (2014) O V Leontieva et al. Cell Death & Disease
- PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways
- (2014) L Chang et al. Cell Death & Disease
- Immunosuppressants in cancer prevention and therapy
- (2014) Mikhail V Blagosklonny OncoImmunology
- Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive
- (2013) Dudley W. Lamming et al. AGING CELL
- Late-life rapamycin treatment reverses age-related heart dysfunction
- (2013) James M. Flynn et al. AGING CELL
- Aging is not programmed
- (2013) Mikhail V Blagosklonny CELL CYCLE
- CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion
- (2013) Olga V. Leontieva et al. CELL CYCLE
- S6K in geroconversion
- (2013) Olga V. Leontieva et al. CELL CYCLE
- Metformin: Do we finally have an anti-aging drug?
- (2013) Vladimir N. Anisimov CELL CYCLE
- MEK drives cyclin D1 hyperelevation during geroconversion
- (2013) O V Leontieva et al. CELL DEATH AND DIFFERENTIATION
- Hsp90 chaperones PPARγ and regulates differentiation and survival of 3T3-L1 adipocytes
- (2013) M T Nguyen et al. CELL DEATH AND DIFFERENTIATION
- p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity
- (2013) A Molchadsky et al. CELL DEATH AND DIFFERENTIATION
- A Central Role for mTOR in Lipid Homeostasis
- (2013) Dudley W. Lamming et al. Cell Metabolism
- mTOR in aging, metabolism, and cancer
- (2013) Marion Cornu et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Aspirin extends the lifespan of Caenorhabditis elegans via AMPK and DAF-16/FOXO in dietary restriction pathway
- (2013) Qin-Li Wan et al. EXPERIMENTAL GERONTOLOGY
- Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
- (2013) Tamara Tchkonia et al. JOURNAL OF CLINICAL INVESTIGATION
- mTOR is a key modulator of ageing and age-related disease
- (2013) Simon C. Johnson et al. NATURE
- mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome
- (2013) S. C. Johnson et al. SCIENCE
- Treatment With Sirolimus Is Associated With Less Weight Gain After Kidney Transplantation
- (2013) Fritz Diekmann et al. TRANSPLANTATION
- Rapamycin Enhances Long-Term Hematopoietic Reconstitution of Ex Vivo Expanded Mouse Hematopoietic Stem Cells by Inhibiting Senescence
- (2013) Yi Luo et al. TRANSPLANTATION
- PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor
- (2013) K Airiau et al. Cell Death & Disease
- TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists
- (2013) M V Blagosklonny Cell Death & Disease
- FoxO1 controls lysosomal acid lipase in adipocytes: implication of lipophagy during nutrient restriction and metformin treatment
- (2013) D Lettieri Barbato et al. Cell Death & Disease
- Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet
- (2013) O V Leontieva et al. Cell Death & Disease
- Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance
- (2013) L Chang et al. Cell Death & Disease
- Metformin improves healthspan and lifespan in mice
- (2013) Alejandro Martin-Montalvo et al. Nature Communications
- Bile acid-induced inflammatory signaling in mice lacking Foxa2 in the liver leads to activation of mTOR and age-onset obesity
- (2013) Irina Mikhailovna Bochkis et al. Molecular Metabolism
- Rapamycin slows aging in mice
- (2012) John E. Wilkinson et al. AGING CELL
- Caveolin-1 and Accelerated Host Aging in the Breast Tumor Microenvironment
- (2012) Isabelle Mercier et al. AMERICAN JOURNAL OF PATHOLOGY
- Prospective Treatment of Age-Related Diseases by Slowing Down Aging
- (2012) Mikhail V. Blagosklonny AMERICAN JOURNAL OF PATHOLOGY
- Rapalogs in cancer prevention
- (2012) Mikhail V. Blagosklonny CANCER BIOLOGY & THERAPY
- Can Propranalol Prevent Hepatocellular Carcinoma?
- (2012) W. T. London et al. Cancer Prevention Research
- Rapamycin-induced glucose intolerance: Hunger or starvation diabetes
- (2012) Mikhail V Blagosklonny CELL CYCLE
- Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
- (2012) Vladimir N. Anisimov et al. CELL CYCLE
- Rapamycin slows aging in mice
- (2012) Adam Spong et al. CELL CYCLE
- Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells
- (2012) Annette Romanski et al. CELL CYCLE
- Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
- (2012) Marina Kolesnichenko et al. CELL CYCLE
- Glutaminolysis feeds mTORC1
- (2012) Raúl V. Durán et al. CELL CYCLE
- RNase L controls terminal adipocyte differentiation, lipids storage and insulin sensitivity via CHOP10 mRNA regulation
- (2012) O Fabre et al. CELL DEATH AND DIFFERENTIATION
- TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO
- (2012) Stacey Robida-Stubbs et al. Cell Metabolism
- mTOR Inhibition Prevents Epithelial Stem Cell Senescence and Protects from Radiation-Induced Mucositis
- (2012) Ramiro Iglesias-Bartolome et al. Cell Stem Cell
- Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence
- (2012) Cecilia A. Hinojosa et al. EXPERIMENTAL GERONTOLOGY
- Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
- (2012) Farhat V.N. Din et al. GASTROENTEROLOGY
- Role of β-adrenergic receptors in regulation of hepatic fat accumulation during aging
- (2012) Paramita M Ghosh et al. JOURNAL OF ENDOCRINOLOGY
- Hypoxia suppresses conversion from proliferative arrest to cellular senescence
- (2012) O. V. Leontieva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy
- (2012) W-Y Shi et al. Cell Death & Disease
- Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
- (2012) Michael N. Pollak Cancer Discovery
- Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2
- (2012) Lan Ye et al. Frontiers in Genetics
- Of mice and men: The benefits of caloric restriction, exercise, and mimetics
- (2011) Evi M. Mercken et al. AGEING RESEARCH REVIEWS
- Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension
- (2011) Chin-Chou Huang et al. AMERICAN JOURNAL OF CARDIOLOGY
- A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs and Hodgkin lymphoma risk in Denmark
- (2011) E T Chang et al. BRITISH JOURNAL OF CANCER
- Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats
- (2011) N Deblon et al. BRITISH JOURNAL OF PHARMACOLOGY
- Metformin slows down aging and extends life span of female SHR mice
- (2011) Vladimir N. Anisimov et al. CELL CYCLE
- Calorie restriction: Decelerating mTOR-driven aging from cells to organisms (including humans)
- (2011) Mikhail V Blagosklonny CELL CYCLE
- From growing to secreting: New roles for mTOR in aging cells
- (2011) Giovambattista Pani CELL CYCLE
- Insulin resistance due to nutrient excess
- (2011) Asish K. Saha et al. CELL CYCLE
- The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis
- (2011) T L Ng et al. CELL DEATH AND DIFFERENTIATION
- mTOR signaling in disease
- (2011) Eva Dazert et al. CURRENT OPINION IN CELL BIOLOGY
- Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
- (2011) Z.-J. Zhang et al. DIABETES CARE
- Target of Rapamycin (TOR) in Nutrient Signaling and Growth Control
- (2011) Robbie Loewith et al. GENETICS
- Beta Blockers and Breast Cancer Mortality: A Population- Based Study
- (2011) Thomas I. Barron et al. JOURNAL OF CLINICAL ONCOLOGY
- Attenuation of Sarcopenia by Dietary Restriction in Rhesus Monkeys
- (2011) R. J. Colman et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
- (2011) John Burn et al. LANCET
- Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling
- (2011) Y. Yu et al. SCIENCE
- The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling
- (2011) P. P. Hsu et al. SCIENCE
- Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes
- (2011) M. Narita et al. SCIENCE
- mTOR couples cellular nutrient sensing to organismal metabolic homeostasis
- (2011) Jessica J. Howell et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
- (2011) T Tomic et al. Cell Death & Disease
- Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
- (2010) Vladimir N. Anisimov et al. AMERICAN JOURNAL OF PATHOLOGY
- Prevention of cancer by inhibiting aging
- (2010) Mikhail V Blagosklonny CANCER BIOLOGY & THERAPY
- Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis
- (2010) R. M. Memmott et al. Cancer Prevention Research
- Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program
- (2010) Mikhail V Blagosklonny CELL CYCLE
- Autophagy in Drosophila ovaries is induced by starvation and is required for oogenesis
- (2010) J M I Barth et al. CELL DEATH AND DIFFERENTIATION
- With TOR, Less Is More: A Key Role for the Conserved Nutrient-Sensing TOR Pathway in Aging
- (2010) Pankaj Kapahi et al. Cell Metabolism
- Mammalian Target of Rapamycin Complex 1 Suppresses Lipolysis, Stimulates Lipogenesis, and Promotes Fat Storage
- (2010) P. Chakrabarti et al. DIABETES
- Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue
- (2010) V. P. Houde et al. DIABETES
- Ageing in Drosophila: The role of the insulin/Igf and TOR signalling network
- (2010) Linda Partridge et al. EXPERIMENTAL GERONTOLOGY
- Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond
- (2010) Lev M Berstein Future Oncology
- DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion
- (2010) F. Rodier et al. JOURNAL OF CELL SCIENCE
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress
- (2010) Shomit Sengupta et al. MOLECULAR CELL
- Long-term use of metformin could protect against breast cancer
- (2010) Linda Koch Nature Reviews Endocrinology
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Dietary Restriction: Standing Up for Sirtuins
- (2010) J. A. Baur et al. SCIENCE
- Extending Healthy Life Span--From Yeast to Humans
- (2010) L. Fontana et al. SCIENCE
- Regression of Left Ventricular Hypertrophy in Kidney Transplant Recipients: The Potential Role for Inhibition of Mammalian Target of Rapamycin
- (2010) E. Paoletti et al. TRANSPLANTATION PROCEEDINGS
- Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy
- (2010) E Morselli et al. Cell Death & Disease
- Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production
- (2009) Luigi Fontana et al. AGE
- Long-term Administration of Rapamycin Reduces Adiposity, but Impairs Glucose Tolerance in High-Fat Diet-fed KK/HlJ Mice
- (2009) Geng-Ruei Chang et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats
- (2009) Edson Lucas Santos et al. BIOCHEMICAL PHARMACOLOGY
- Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels
- (2009) Wen Qiang Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Disruption of the Ang II type 1 receptor promotes longevity in mice
- (2009) Ariela Benigni et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapamycin Protects Against High Fat Diet–Induced Obesity in C57BL/6J Mice
- (2009) Geng-Ruei Chang et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Nonsteroidal Anti-inflammatory Drug Use After 3 Years of Aspirin Use and Colorectal Adenoma Risk: Observational Follow-up of a Randomized Study
- (2009) Maria V. Grau et al. JNCI-Journal of the National Cancer Institute
- Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway
- (2009) Hui H. Zhang et al. PLoS One
- Mammalian Target of Rapamycin and Diabetes: What Does the Current Evidence Tell Us?
- (2009) B. Vodenik et al. TRANSPLANTATION PROCEEDINGS
- Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice
- (2008) Randy Strong et al. AGING CELL
- Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging
- (2008) Hélène Bulckaen et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Effect of Metformin-Containing Antidiabetic Regimens on All-cause Mortality in Veterans With Type 2 Diabetes Mellitus
- (2008) Therese A. Mangold et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- A chronic increase in physical activity inhibits fed-state mTOR/S6K1 signaling and reduces IRS-1 serine phosphorylation in rat skeletal muscle
- (2008) Erin L. Glynn et al. Applied Physiology Nutrition and Metabolism
- Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals
- (2008) Michael Lefevre et al. ATHEROSCLEROSIS
- EFFECT OF CHRONIC ASPIRIN ADMINISTRATION ON AN EXPERIMENTAL MODEL OF METABOLIC SYNDROME
- (2008) Nicolás F Renna et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- The role of mTOR in the adaptation and failure of β-cells in type 2 diabetes
- (2008) G. Leibowitz et al. DIABETES OBESITY & METABOLISM
- Enhanced activation of a “nutrient-sensing” pathway with age contributes to insulin resistance
- (2008) Francine H. Einstein et al. FASEB JOURNAL
- Biphasic Response of Pancreatic -Cell Mass to Ablation of Tuberous Sclerosis Complex 2 in Mice
- (2008) Y. Shigeyama et al. MOLECULAR AND CELLULAR BIOLOGY
- Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients
- (2008) Jordi Rovira et al. TRANSPLANT INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now